Gestational diabetes affects millions of women in the world and, in many cases, is detected when metabolic damage has already begun. Faced with this scenario, specialists from UNAM and Inmegen developed an innovative molecular test capable of identifying risk from the first trimester of pregnancy, months before traditional methods. Gestational diabetes, one of the main threats in pregnancy This disease could cease to be a silent threat to millio…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Gestational diabetes affects millions of women in the world and, in many cases, is detected when metabolic damage has already begun. Faced with this scenario, specialists from UNAM and Inmegen developed an innovative molecular test capable of identifying risk from the first trimester of pregnancy, months before traditional methods. Gestational diabetes, one of the main threats in pregnancy This disease could cease to be a silent threat to millio…